Literature DB >> 18432261

Quantitative monitoring of cell clones carrying point mutations in the BCR-ABL tyrosine kinase domain by ligation-dependent polymerase chain reaction (LD-PCR).

S Preuner, D Denk, F Frommlet, M Nesslboeck, T Lion.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18432261     DOI： 10.1038/leu.2008.97

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.

Authors:  Simona Soverini; Antonella Vitale; Angela Poerio; Alessandra Gnani; Sabrina Colarossi; Ilaria Iacobucci; Giuseppe Cimino; Loredana Elia; Annalisa Lonetti; Marco Vignetti; Stefania Paolini; Giovanna Meloni; Valeria di Maio; Cristina Papayannidis; Marilina Amabile; Anna Guarini; Michele Baccarani; Giovanni Martinelli; Robin Foà
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

2.  Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.

Authors:  Peter Valent; Thomas Lion; Dominik Wolf; Christian Sillaber; Hermine Agis; Andreas Petzer; Alois Lang; Peter Kalhs; Dietmar Geissler; Richard Greil; Werner Linkesch; Sonja Burgstaller; Josef Thaler; Günther Gastl
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 3.  [Current diagnostic requirements in chronic myeloid leukemia].

Authors:  Thomas Lion; Gerald Webersinke; Ulrike Kastner; Christoph Seger; Gerlinde Mitterbauer-Hohendanner; Günther Gastl
Journal:  Wien Med Wochenschr       Date:  2013-10-01

4.  CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.

Authors:  Mathias Schneeweiss-Gleixner; Konstantin Byrgazov; Gabriele Stefanzl; Daniela Berger; Gregor Eisenwort; Chantal Blanche Lucini; Susanne Herndlhofer; Sandra Preuner; Klara Obrova; Petra Pusic; Nadine Witzeneder; Georg Greiner; Gregor Hoermann; Wolfgang R Sperr; Thomas Lion; Michael Deininger; Peter Valent; Karoline V Gleixner
Journal:  EBioMedicine       Date:  2019-11-21       Impact factor: 8.143

5.  Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.

Authors:  R Kastner; A Zopf; S Preuner; J Pröll; N Niklas; P Foskett; P Valent; T Lion; C Gabriel
Journal:  Eur J Cancer       Date:  2013-12-20       Impact factor: 9.162

6.  Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches.

Authors:  Sandra Preuner; Agnes Barna; Florian Frommlet; Stefan Czurda; Byrgazov Konstantin; Mary Alikian; Katerina Machova Polakova; Tomasz Sacha; Johan Richter; Thomas Lion; Christian Gabriel
Journal:  Int J Mol Sci       Date:  2016-04-29       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.